Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,266,686 | 966,476 | 612,814 | 308,766 | 898,573 |
| Depreciation Amortization | 358,933 | 270,212 | 182,845 | 92,545 | 355,744 |
| Income taxes - deferred | 153,576 | 115,698 | 48,626 | 71,974 | -81,410 |
| Accounts receivable | -73,374 | -17,334 | -54,909 | -90,712 | -99,227 |
| Other Working Capital | -184,612 | -169,751 | -191,655 | -233,137 | 3,559 |
| Other Operating Activity | 206,532 | 88,466 | 85,523 | 104,142 | 547,434 |
| Operating Cash Flow | $1,727,741 | $1,253,767 | $683,244 | $253,578 | $1,624,673 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -208,020 | -137,578 | -86,229 | -32,143 | -173,055 |
| Net Acquisitions | -5,000 | N/A | N/A | N/A | -157,428 |
| Purchase Of Investment | -3,696,995 | -2,590,971 | -1,778,568 | -908,730 | -1,992,886 |
| Sale Of Investment | 2,276,720 | 1,476,052 | 1,169,836 | 788,083 | 2,668,694 |
| Other Investing Activity | -16,999 | -8,265 | 21,376 | 25,995 | 0 |
| Investing Cash Flow | $-1,650,294 | $-1,260,762 | $-673,585 | $-126,795 | $345,325 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -11,459 | N/A | N/A | N/A | -18,073 |
| Common Stock Issued | 314,650 | 299,466 | 285,883 | 91,155 | 183,486 |
| Common Stock Repurchased | -497,975 | -386,575 | -386,575 | -195,287 | -2,077,579 |
| Other Financing Activity | -125,078 | -89,944 | 22,767 | 4,300 | 127,247 |
| Financing Cash Flow | $-319,862 | $-177,053 | $-77,925 | $-99,832 | $-1,784,919 |
| Exchange Rate Effect | -2,641 | -410 | 6,194 | 4,126 | -7,370 |
| Beginning Cash Position | 759,598 | 759,598 | 759,598 | 759,598 | 581,889 |
| End Cash Position | 514,542 | 575,140 | 697,526 | 790,675 | 759,598 |
| Net Cash Flow | $-245,056 | $-184,458 | $-62,072 | $31,077 | $177,709 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,727,741 | 1,253,767 | 683,244 | 253,578 | 1,624,673 |
| Capital Expenditure | -208,020 | -137,578 | -86,229 | -32,143 | -173,055 |
| Free Cash Flow | 1,519,721 | 1,116,189 | 597,015 | 221,435 | 1,451,618 |